NIH

Ehrenfeld’s LGBTQ health research lauded by NIH

Vanderbilt University Medical Center’s Jesse Ehrenfeld, MD, MPH, recently received the inaugural Sexual and Gender Minority Research Investigator Award from the National Institutes of Health (NIH).

By VUMC News and Communications

array of test tubes with pipette dropping fluid into one

Destructive ‘telegrams’ in asthma

Vanderbilt investigators have discovered that certain microRNAs — “telegram”-like signals — increase after the induction of allergic airway inflammation.

New target for chronic kidney disease

Preventing the formation of secretory structures that promote scarring in the kidney could offer new therapeutic options for a disease that affects millions of people worldwide.

Cell death pathway implicated in bone marrow failure

Vanderbilt investigators have linked a specific form of programmed cell death to myelodysplastic syndrome, a type of bone marrow failure.

Nasal whooping cough vaccine trial underway at Vanderbilt

Vanderbilt vaccine researchers are enrolling adult volunteers in a National Institutes of Health (NIH)-sponsored Phase II clinical trial that will study a next generation pertussis vaccine that may protect people from whooping cough.

By Craig Boerner

January 17, 2019

Signals from the “conveyor belt”

Vanderbilt researchers propose that cellular signaling pathways are amplified by a “conveyor belt” mechanism that exchanges active and inactive enzymes.